- Open Access
Economic costs of fever to households in the middle belt of Ghana
© Tawiah et al. 2016
- Received: 3 June 2015
- Accepted: 21 January 2016
- Published: 6 February 2016
Malaria is one of the main health problems in the sub-Saharan Africa accounting for approximately 198 million morbidity and close to 600,000 mortality cases. Households incur out-of-pocket expenditure for treatment and lose income as a result of not being able to work or care for family members. The main objective of this survey was to assess the economic cost of treating malaria and/or fever with the new ACT to households in the Kintampo districts of Ghana where a health and demographic surveillance systems (KHDSS) are set up to document population dynamics.
The study was a cross-sectional survey conducted from October 2009 to July 2011 using community members’ accessed using KHDSS population in the Kintampo area. An estimated sample size of 4226 was randomly selected from the active members of the KHDSS. A structured questionnaire was administered to the selected populates who reported of fever within the last 2 weeks prior to the visit. Data was collected on treatment-seeking behaviour, direct and indirect costs of malaria from the patient perspective.
Of the 4226 households selected, 947 households with 1222 household members had fever out of which 92 % sought treatment outside home; 55 % of these were females. 31.6 % of these patients sought care from chemical shops. A mean amount of GHS 4.2 (US$2.76) and GHS 18.0 (US$11.84) were incurred by households as direct and indirect cost respectively. On average a household incurred a total cost of GHS 22.2 (US$14.61) per patient per episode. Total economic cost was lowest for those in the highest quintile and highest for those in the middle quintile.
The total cost of treating fever/malaria episode is relatively high in the study area considering the poverty levels in Ghana. The NHIS has positively influenced health-seeking behaviours and reduced the financial burden of seeking care for those that are insured.
- Treatment-seeking behaviour
- Direct cost
- Indirect cost
Malaria is one of the main health problems in sub-Saharan Africa . In 2013, there was an estimated 198 million cases of malaria with estimated deaths of 584,000 in Africa . The annual reported confirmed malaria cases in Ghana in 2013 were about 1.6 million out of which 2506 resulted in deaths. In addition to being responsible for a high rate of morbidity and mortality, malaria can lead to impaired cognitive development and learning abilities , school absenteeism  and low levels of attention at school .
Malaria and its associated costs present a major socio-economic challenge to households in Africa. It leads to considerable economic burden at the household level and the poorest households in the population are mostly affected [6, 7]. Households are affected through out-of-pocket expenditure for treatment and by the loss of income as a result of not being able to work or care for family members. Cost of malaria constitutes significant shares of annual household incomes ranging from 6 to 13 % depending on the burden of malaria [8, 9]. Cost of time lost to patients and caretakers as a result of the disease constitute more than fifty percent of total cost of treating malaria [6, 7]. Loss of working days due to malaria by a sick adult in some malaria endemic areas of Africa has reported a range between 6–9 days. This leads to substantial loss of productive man-hours to households, resulting in decrease in household income [6, 10–12]. Malaria in Africa has been reported to cause about 1.3 % reduction in annual economic growth rate [10, 13, 14].
WHO recommended treatment of malaria with combination therapy preferably those which contain artemisinin  for countries suffering from malaria. This is because artemisinin-based combination therapy (ACT) has been known to be safe and effective with known slow emergent resistance by malaria parasites. Ghana introduced ACT as the first-line drug for the treatment of uncomplicated malaria in 2004 . Though ACT is safe and effective compared to monotherapies, it is however much more expensive . This survey sought to assess the economic cost of treatment-seeking for malaria and/or fever with the new ACT to households in the Kintampo municipality of Ghana. This study is part of INDEPTH Phase IV Safety and Effectiveness Studies (INESS) carried out between 2009 and 2011 as part of assessing the real life determinants of effectiveness of new anti-malarials that are introduced after licensure .
Kintampo districts cover an area of approximately bout 7162 km2 a resident population size of about 150,000 inhabitants in 29,438 households . Kintampo Health Research Center (KHRC) located in the Kintampo districts maintains the Kintampo Health and Demographic Surveillance System (KHDSS), which was used for sampling households for this study. The KHDSS routinely collects demographic information on age, sex, pregnancies, births, deaths, and migrations among others and does verbal autopsies to determine the cause of deaths . The site also collects data on household assets and possessions that enable the assessment of socio-economic status of the population. There are two hospitals, twenty health centres, three private clinics and five public Community Health Planning Services (CHPS) compound in the study area. At the time of this study about 50 %  of inhabitants in the study area had valid National Health Insurance cards to access health care in public and private accredited by the National Health Insurance Authority (NHIA). Currently, health insurance coverage is about 66 % . The study area is mainly rural with few urban settlements. Farming is the main economic activity in the area. Malaria accounts for more than half of all out-patient visits in the study area .
This was a cost analysis study based on patient’s perspective. A cross-sectional household survey was conducted between October 2009 and September 2011 among community members in the Kintampo area located in the middle part of Ghana.
Participant selection and data collection
Assuming 6 % of the entire inhabitants will have had fever in the 2 weeks prior to the day of interview and that 50 % of them will seek care and have physical access to an authorized point of provision of ACT: then with 95 % confidence and allowing for 10 % drop-out, the estimated sample size of 4226 households will be achieved. Households were randomly selected from the 4226 households using the KHDSS household database and interviewed with a structured questionnaire. Household members who reported of fever within the last 2 weeks prior to their interview were included in the survey. However, only those who sought treatment outside their homes and incurred costs in seeking treatment were included in the analysis. Data was obtained from household members on socio-demographic characteristics, treatment-seeking patterns as well as direct and indirect costs of seeking treatment outside home.
Data management and analysis
Data was double-entered into Epidata 3.1 (THE EPIDATA ASSOCIATION, ODENSE M, DENMARK, EUROPE) and transferred to Stata 11.0© (STATA CORP. TX) for analysis. The total economic cost of fever per household was estimated by summing the direct and indirect costs incurred per household. The estimated mean and median costs with their respective 25th and 75th percentiles (iqr) and standard deviations (SD) are presented. Direct costs were defined as out-of-pocket expenditure incurred by the households as a result of seeking treatment for their fever outside their homes. It included cost of self-treatment, medical costs and non-medical costs. Cost of self-treatment comprised the cost of medicines purchased from pharmacies, chemical and other drug sellers without prescription from a doctor or medical staff at a health facility. Medical costs included consultation, laboratory and prescription fees incurred at a health facility. Non-medical cost included cost of transportation to and from the facility where care was sought and other non-medical costs incurred as a result of seeking health care for the treatment of fever.
Indirect cost was defined as the cost of productivity losses to households as a result of their fever and inability to work. It was calculated as a product of the number of days respondents were unable to work and their daily wage. Daily wage was estimated in several ways depending on the type of economic activity the respondent was involved. The daily wage for economically active adults (defined as persons aged 18 years and above; and engaged in informal income generating activities, such as farming) who hired others to do their work during the course of the fever was calculated as the cost paid out to others to get the work done. Among patients who earned monthly income, daily wage was estimated as their total monthly income divided by 22 days with the assumption that they worked 5 days per week for a month of 4 weeks. Students were asked to report on the number of school days missed due to fever. When adult patients were accompanied by caretakers, the daily wage of their caretaker was estimated in a similar manner for the patients. Seeking care outside home was defined as seeking care from the public or private health facilities, chemist or pharmacist and herbalist or drug peddler.
Wealth quintiles for each household were calculated using Principal Component Analysis (PCA) and included durable households’ possessions such as motorbike, car, bed, radio and sewing machine. Information on household architecture of material for walls, roofing material, source of drinking water, cooking utensils, toilet facility and cooking fuel [24–26] were also obtained. Exchange rate (as at 30th September 2011): GHS 1.52 is equivalent to $1 .
Written informed consent was obtained from all adult participants and from care-takers of children. Additionally, assent was sought from participants who were between 12–18 years. The Kintampo Institutional Ethics Committee and the Ghana Health Service Ethical Review Committee granted ethical approval for the study.
Had fever and sought care outside home
Age groups (years)
Households’ treatment-seeking behaviour
Name of provider
Wealth quintile groupings
Chemical seller Shop
Households mode of payment for cost of fever
Days lost due to fever and to productivity
Days lost to productivity by socio-demographic groups
iqr (25th–75th percentile)
Age groups (years)
Choice of provider and days lost to productivity
Total days lost
Mean days lost
iqr (25th–75th percentile)
Chemical seller shop
Total cost of treating fever
Direct, indirect and total economic costs of fever
Total cost GHS
Mean cost per patient GHS
iqr (25th–75th percentile) GHS
All direct cost
Direct cost of self-treatment
All indirect cost
Indirect cost by occupation
Formal sector employees
Under 18 years
Cost by health facility attended
Economic burden of fever cost on household’s income
monthly income (GHS)
Mean economic cost
of fever (GHS)
Share of cost on
The overall mean cost of fever was GHS 22.2 ($14.6). This is high given that the study area is predominantly rural with relatively poor inhabitants. The results also showed that the cost was higher for those in the lower wealth quintile quintiles compared to those in the higher wealth quintiles. This trend can have a number of effects on the poor. For example, it can prevent the poor from seeking care when they have a fever episode. This is especially true if they are not members of the NHIS and will have to pay out of their pockets for health care. High cost combined with out-of-pocket payments can lead to catastrophic payments by the poor which can further cause the poor to be poorer and also push those above the poverty line into impoverishment [28–30].
The study findings further showed that the cost was highest for those who attended hospitals [GHS 30.1]. Direct medical cost was identified to form the highest component of the direct costs incurred by households and this was influenced mostly by the cost of hospitalization. This was probably because patients attended the hospitals when their fever was severe and required more days for treatment and extensive treatment and services including hospitalization in most cases. The average number of days lost due to fever by patients (4.2 days) and days absent from school (2.4 days) were comparable to findings from other settings. For instance, in related studies in Ghana and Ethiopia [10, 12, 31], the number of days lost due to malaria by patients and the lost school days ranged between three to nine days [6, 10, 11]. The number of days lost, to some extent influenced the productivity losses for the respondents. Productivity losses are worrying due to the fact that most inhabitants in the study area are farmers and peak malaria season coincides with the rainy seasons. Days lost to fever affect household’s productivity and this in effect affects household’s income and also the national economy.
Unlike other studies where households mostly borrowed money or sold their assets to cover the cost of health care [32, 33], the majority of respondents in this study paid for care of febrile illness using their health insurance or cash. Respondents who paid out-of-pocket were mostly those in the lowest quintile. Out-of-pocket payment as a health financing mechanism is known to be regressive  rather than progressive: as poorer households bear a higher burden of the cost compared to the richer households. The economic burden of the cost of fever presented in this study was higher on those in the lower wealth quintiles compared to those in the higher wealth quintiles as they used a greater share of their monthly mean income to cover the cost of treating their fever.
Household members sought care from different sources when they had a fever and majority of the respondents sought care from the formal health care facilities (private clinics, hospitals, health centres, CHPs compounds) [6, 35]. The result suggests that treatment-seeking behaviour has changed compared to the past decade when households resorted to home treatments [6, 35]. This positive trend of care-seeking behaviour can help minimize self-medication and misguided traditional treatment and their associated complications and costs. The encouraging trend of seeking care from formal health care facilities could be because majority of health facilities are health insurance service providers while community based licensed chemical sellers are not. It is, therefore, anticipated that an increase in the National Health Insurance Scheme (NHIS) coverage in the area could positively influence households to seek care in formal health care facilities. The positive impact of NHIS on formal health care attendance is corroborated in other studies [36–38].
Despite these findings, there are some limitations to this study. Firstly, the study used self-reported fever to indicate malaria. Although not all fevers are malaria, in Ghana fever is mostly associated with malaria. Secondly, the costs presented in this study may not be transferable to other contexts where health-seeking behaviour, insurance coverage, and occupation differ from those in rural Ghana. Finally, there was recall bias as participants were asked to recall over a period of 2 weeks. There is possibility of either underestimation or overestimation as they reported expenditure verbally without producing receipts.
The total cost of fever episode of GHS 22.2 (US$14.61) is quite high considering the poverty level in the middle belt of Ghana especially the study setting were majority of the households live below the poverty level. The burden of fever falls disproportionately on poor households as close to five working days are lost due to fever which may further push them into poverty. The NHIS has positively influenced health-seeking behaviours and reduced the financial burden of seeking care to those that are insured.
TT contributed in the conception, design, and collection of data, analysis, interpretation, and drafting of the manuscript. KPA, SOA, PA, conceived the idea, contributed to design, collection of data, analysis, interpretation, and drafting of the manuscript. AK contributed to the collection of data. LA contributed to the conception, design and collection of data. RAD, KH contributed in analysis and drafting of the manuscript. SAE, EM and SG contributed to the analysis of the data. All authors gave final approval of the version to be published. All authors read and approved the final manuscript.
This research was supported by the Bill and Melinda Gate foundation and was facilitated by the INDEPTH Network. The authors are grateful to data managers and the data entry clerks for processing the data at KHRC. The authors are also thankful to the Kintampo Health Demographic Surveillance System team and the people of Kintampo North and South district for their support during the data collection.
The authors declare that there are no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- WHO. Malaria. World Health Organization fact sheet 94; 2015. http://www.who.int/mediacentre/factsheets/fs094/en.
- WHO. World Malaria Report. Geneva: World Health Organization; 2014.Google Scholar
- Holding P, Snow R. Impact of Plasmodium falciparum malaria on performance and learning: review of the evidence. Am J Trop Med Hyg. 2001;64(1 suppl):68–75.PubMedGoogle Scholar
- Brooker S, Guyatt H, Omumbo J, Shretta R, Drake L, Ouma J. Situation analysis of malaria in school-aged children in Kenya—what can be done? Parasitol Today. 2000;16:183–6.View ArticlePubMedGoogle Scholar
- Clarke SE, Jukes MCH, Njagi JK, Khasakhala L, Cundill B, Otido J, et al. Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:127–38.PubMed CentralView ArticlePubMedGoogle Scholar
- Akazili J, Aikins M, Binka FN. Malaria treatment in Northern Ghana: what is the treatment cost per case to households? Afr J Health Sci. 2007;14:70–9.Google Scholar
- Somi MF, Butler JRG, Vahid F, Njau JD, Kachur SP, Abdulla S. Economic burden of malaria in rural Tanzania: variations by socioeconomic status and season. Trop Med Int Health. 2007;12:1139–47.View ArticlePubMedGoogle Scholar
- Chuma JM, Thiede M, Molyneux CS. Rethinking the economic costs of malaria at the household level: evidence from applying a new analytical framework in rural Kenya. Malar J. 2006;5:76.PubMed CentralView ArticlePubMedGoogle Scholar
- Morel CM, Thang ND, Xa NX, Hung LX, Thuan LK, Van Ky P, et al. The economic burden of malaria on the household in south-central Vietnam. Malar J. 2008;7:166.PubMed CentralView ArticlePubMedGoogle Scholar
- Deressa W, Hailemariam D, Ali A. Economic costs of epidemic malaria to households in rural Ethiopia. Trop Med Int Health. 2007;12:1148–56.View ArticlePubMedGoogle Scholar
- Asante FA, Asenso-Okyere K. Economic burden of malaria in Ghana. Final Report ISSER, Univ of Ghana; 2003.Google Scholar
- Asante FA, Okyere WA, Kusi A. The economic impact of the burden of malaria in Ghana. Institute of Statistical, Social, and Economic Research, University of Ghana, Legon; 2005.Google Scholar
- Malaney P, Spielman A, Sachs J. The malaria gap. Am J Trop Med Hyg. 2004;71(2 suppl):141–6.PubMedGoogle Scholar
- Sachs J, Malaney P. The economic and social burden of malaria. Nature. 2002;415:680–5.View ArticlePubMedGoogle Scholar
- WHO: World malaria report 2011. Geneva, World Health Organization, 2011.Google Scholar
- Koram K, Quaye L, Abuaku B. Efficacy of amodiaquine/artesunate combination therapy for uncomplicated malaria in children under five years in Ghana. Ghana Med J. 2008;42:55–60.PubMed CentralPubMedGoogle Scholar
- Wiseman V, Kim M, Mutabingwa TK, Whitty CJ. Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS Med. 2006;3:e373.PubMed CentralView ArticlePubMedGoogle Scholar
- Khatib RA, Selemani M, Mrisho GA, Masanja IM, Amuri M, Njozi MH, et al. Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania. Malar J. 2013;12:155.PubMed CentralView ArticlePubMedGoogle Scholar
- Kintampo Health Research Center. Annual Report. 2010.Google Scholar
- Owusu-Agyei S, Nettey OEA, Zandoh C, Sulemana A, Adda R, Amenga-Etego S, et al. Demographic patterns and trends in Central Ghana: baseline indicators from the Kintampo Health and Demographic Surveillance System. Global Health Action. 2012;5:1–11.View ArticlePubMedGoogle Scholar
- Kintampo North Municipal Health Insurance Scheme. Annual Report. 2010.Google Scholar
- Kintampo North Municipal Health Insurance Scheme. Annual Report: 2013.Google Scholar
- Kintampo Municipal Health Directoriate. Annual Report. 2010.Google Scholar
- Howe LD, Galobardes B, Matijasevich A, Gordon D, Johnston D, Onwujekwe O, et al. Measuring socio-economic position for epidemiological studies in low- and middle-income countries: a methods of measurement in epidemiology paper. Int J Epidemiol. 2012;41:871–86.PubMed CentralView ArticlePubMedGoogle Scholar
- Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan. 2006;21:459–68.View ArticlePubMedGoogle Scholar
- Houweling TA, Kunst AE, Mackenbach JP. Measuring health inequality among children in developing countries: does the choice of the indicator of economic status matter? Int J Equity Health. 2003;2:8.PubMed CentralView ArticlePubMedGoogle Scholar
- Bank of Ghana. Daily Interbank FX Rates. 2011.Google Scholar
- Chuma J, Maina T. Catastrophic health care spending and impoverishment in Kenya. BMC Health Serv Res. 2012;12:413.PubMed CentralView ArticlePubMedGoogle Scholar
- Ladusingh L, Pandey A. Health expenditure and impoverishment in India. J Health Manag. 2013;15:57–74.View ArticleGoogle Scholar
- Baeza C, Packard T, Torres FM. Beyond survival: protecting households from health shocks in Latin America. Redwood City: Stanford University Press; 2006.Google Scholar
- Asenso-Okyere W, Dzator JA. Household cost of seeking malaria care. A retrospective study of two districts in Ghana. Soc Sci Med. 1997;45:659–67.View ArticlePubMedGoogle Scholar
- Kruk ME, Goldmann E, Galea S. Borrowing and selling to pay for health care in low-and middle-income countries. Health Aff. 2009;28:1056–66.View ArticleGoogle Scholar
- Sauerborn R, Adams A, Hien M. Household strategies to cope with the economic costs of illness. Soc Sci Med. 1996;43:291–301.View ArticlePubMedGoogle Scholar
- Mills A, Ataguba JE, Akazili J, Borghi J, Garshong B, Makawia S, et al. Equity in financing and use of health care in Ghana, South Africa, and Tanzania: implications for paths to universal coverage. Lancet. 2012;380:126–33.View ArticlePubMedGoogle Scholar
- Asante K, Abokyi L, Zandoh C, Owusu R, Awini E, Sulemana A, et al. Community perceptions of malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combination therapy. BMC Public Health. 2010;10:409.PubMed CentralView ArticlePubMedGoogle Scholar
- Gobah FF, Liang Z. The National Health Insurance Scheme in Ghana: prospects and challenges: a cross-sectional evidence. Glob J Health Sci. 2011;3:90–101.Google Scholar
- Jütting JP. Do community-based health insurance schemes improve poor people’s access to health care? Evidence from rural Senegal. World Dev. 2004;32:273–88.View ArticleGoogle Scholar
- Franco LM, Diop FP, Burgert CR, Kelley AG, Makinen M, Simpara CHT. Effects of mutual health organizations on use of priority health-care services in urban and rural Mali: a case–control study. Bull World Health Organ. 2008;86:830–8.PubMed CentralView ArticlePubMedGoogle Scholar